SynGen
Latest round
- Series A
Last raised
- Apr 2012
Total raised
- $5M
Investors
- 1
About SynGen
SynGen Inc.SynGen Inc. specializes in creating innovative solutions for cell separation and isolation in the regenerative medicine industry.50 mn from GE Capital in October 2014.SynGen Inc. specializes in the development of advanced cell separation tools and accessories tailored for regenerative medicine workflows. The company’s core product offerings include innovative devices designed for the efficient separation and isolation of therapeutic cells, which enhance the recovery of target cells while minimizing contamination from unwanted cells. These products aim to improve the overall productivity and efficacy of cell therapy processes, streamlining workflows for researchers and clinicians in the field. The end users predominantly consist of medical researchers, clinical laboratories, and healthcare professionals involved in regenerative medicine and cell therapy applications.SynGen Inc. operates with a revenue model that centers around business-to-business (B2B) transactions, providing its products and services directly to research institutions, clinical settings, and medical organizations. The company facilitates sales through direct orders or partnerships with distributors, ensuring broad accessibility to its innovative separation systems. Transactions involve bulk purchases of equipment and accessories, as well as ongoing service agreements for maintenance and support.SynGen Inc. is actively working on designing new products that cater to the evolving needs in regenerative medicine, with plans for launch in upcoming years. The company aims to expand its reach into new markets, particularly targeting regions in Asia and Europe by 2025.
Who invested in SynGen
1 investor across 1 round
See all investors in SynGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 18, 2012
Amount
$5M
Investors
Questions about SynGen
Who invested in SynGen?
SynGen has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SynGen raised?
SynGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SynGen last raise money?
SynGen's most recent round on record is a Series A, in Apr 2012.
What does SynGen do?
SynGen is a medical devices & equipment company.
Where is SynGen headquartered?
SynGen is headquartered in San Carlos, US.
Which VCs invest in companies like SynGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at SynGen's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like SynGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.